Registro:

Referencias:

• Hirano, T., Interleukin-6 (1994) The cytokine handbook, pp. 145-168. , A.W. Thomson, editor. Academic Press Limited. London, United Kingdom
• Kishimoto, T., Taga, T., Akira, S., Cytokine signal transduction (1994) Cell, 76, pp. 253-262
• Kishimoto, T., Akira, S., Narazaki, M., Taga, T., Interleukin-6 family of cytokines and gp130 (1995) Blood, 86, pp. 1243-1254
• Ray, D., Melmed, S., Pituitary cytokine and growth factor expression and action (1997) Endocr. Rev., 18, pp. 206-228
• Arzt, E., Pathophysiological role of the cytokine network in the anterior pituitary gland (1999) Front. Neuroendocrinol., 20, pp. 71-95
• Heinrich, P.C., Behrmann, I., Muller-Newen, G., Schaper, F., Graeve, L., Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway (1998) Biochem. J., 334, pp. 297-314
• Barton, V.A., Hall, M.A., Hudson, K.R., Heath, J.K., Interleukin-11 signals through the formation of a hexameric receptor complex (2000) J. Biol. Chem., 275, pp. 36197-36203
• Auernhammer, C.J., Melmed, S., The central role of SOCS-3 in integrating the neuro-immunoendocrine interface (2001) J. Clin. Invest., 108, pp. 1735-1740
• Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P.C., Schaper, F., SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP-2 recruitment site of gp130 (2000) J. Biol. Chem., 275, pp. 12848-12856
• Takeda, K., Targeted disruption of the mouse Stat3 gene leads to early embryonic lathality (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 3801-3804
• Yoshida, K., Targeted disruption of gp 130, a common signal transducer for the interleukin-6 family, leads to myocardial and hematological disorders (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 407-411
• Rodig, S.J., Disruption of the JaK1 gene demostrates obligatory and nonredundant roles of the JaKs in cytokine-induced biologic responses (1998) Cell, 93, pp. 373-383
• Shimon, I., Yan, X., Ray, D.W., Melmed, S., Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocoticotropin hormone and growth hormone secretion (1997) J. Clin. Invest., 100, pp. 357-363
• Akita, S., Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion (1995) J. Clin. Invest., 95, pp. 1288-1298
• Wang, Z., Ren, S.G., Melmed, S., Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: A novel endotoxin-inducible neuro-endocrine interface (1996) Endocrinology, 137, pp. 2947-2953
• Ohmichi, M., Binding sites for interleukin-6 in the anterior pituitary gland (1992) Neuroendocrinology, 55, pp. 199-203
• Spangelo, B.L., MacLeod, R.M., Isakson, P.C., Production of interleukin-6 by anterior pituitary cells in vitro (1990) Endocrinology, 126, pp. 582-586
• Vankelecom, H., Carmeliet, P., Van Damme, J., Billiau, A., Denef, C., Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system (1989) Neuroendocrinology, 49, pp. 102-106
• Spangelo, B.L., Gorospe, W.C., Role of the cytokines in the neuroendocrine-immune system axis (1995) Front. Neuroendocrinol., 16, pp. 1-12
• Lohrer, P., Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38a mitogen-activated protein kinase/nuclear factor-κB pathway (2000) Endocrinology, 141, pp. 4457-4465
• Páez Pereda, M., Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corcicotroph pituitary adenomas (2000) Exp. Clin. Endocrinol. Diabetes, 108, pp. 202-207
• Ferrara, N., Winer, J., Henzel, W.J., Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: Identification as leukemia inhibitor factor (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 698-702
• Auernhammer, C.J., Melmed, S., Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: Evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis (1999) Endocrinology, 140, pp. 1559-1566
• Perez Castro, C., The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines (2000) Endocrinology, 141, pp. 1746-1753
• Perez Castro, C., Effects of the gp130 cytokines CNTF and IL-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of PRL and GH secretion in normal rat anterior pituitary aggregate cultures (2001) J. Endocrinol., 169, pp. 539-547
• Arzt, E., Interleukin involvement in anterior pituitary cell growth regulation: Effects of interleukin-2 (IL-2) and IL-6 (1993) Endocrinology, 132, pp. 459-467
• Renner, U., Gloddek, J., Arzt, E., Inoue, K., Stalla, G.K., Interleukin-6 is an autocrine growth factor for TTT/GF mouse pituitary cells (1997) Exp. Clin. Endocrinol. Diabetes, 105, pp. 345-352
• Sawada, T., Interleukin-6 stimulates cell proliferation of rat anterior pituitary clonal cell lines in vicro (1995) J. Endocrinol. Invest., 18, pp. 83-90
• Koyama, C., Pituitary Folliculo-stellate-like cells stimulate somatotropic pituitary tumor growth in nude mice (1995) Endocr. Pathol., 6, pp. 67-75
• Stefana, B., Ray, D.W., Melmed, S., Leukemia inhibitory factor (LIF) induces differentiation of pituitary corticotroph function: A neuroendocrine phenotypic switch (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 12502-12506
• Páez Pereda, M., Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants (1996) Mol. Cell. Endocrinol., 124, pp. 33-42
• Jones, T.H., Justice, S.K., Effect of interleukin-6 on human pituitary tumor cell growth (1995) J. Endocrinol., 144, pp. P292. , Abstr
• Hirano, T., Ishihara, K., Hibi, M., Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family ofcytokine receptors (2000) Oncogene, 19, pp. 2548-2556
• Ray, D.W., Ren, S.G., Melmed, S., Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway (1996) J. Clin. Invest., 97, pp. 1852-1859
• Akita, S., Malkin, J., Melmed, S., Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion (1996) Endocrinology, 137, pp. 3140-3143
• Chesnokova, V., Auerhamer, C.J., Melmed, S., Murine LIF gene disruption attenuates the hypothalamio-pituitary-adrenal axis stress response (1998) Endocrinology, 139, pp. 2209-2216
• Bousquet, C., Susini, C., Melmed, S., Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin by leukemia inhibitory factor (1999) J. Clin. Invest., 104, pp. 1277-1285
• Auernhammer, C.J., Chesnokova, V., Bousquet, C., Melmed, S., Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion (1998) Mol. Endocrinol., 12, pp. 954-961
• Bousquet, C., Melmed, S., Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling (1999) J. Biol. Chem., 274, pp. 10723-10730
• Bousquet, C., Zatelli, M.C., Melmed, S., Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-nueroendocrine interfacing (2000) J. Clin. Invest., 106, pp. 1417-1425
• Bousquet, C., Chesnokova, V., Kariagina, A., Ferrad, A., Melmed, S., cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: Novel negative feedback mechanism for corticotroph cytokine action (2001) Mol. Endocrinol., 15, pp. 1880-1890

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------